Exelixis: Q4 Earnings Snapshot
By AP News
Published - Feb 07, 2023, 05:03 PM ET
Last Updated - Jun 22, 2023, 10:50 PM EDT
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Exelixis Inc. (EXEL) on Tuesday reported a fourth-quarter loss of $30.2 million, after reporting a profit in the same period a year earlier.
The Alameda, California-based company said it had a loss of 9 cents per share. Losses, adjusted for stock option expense, came to 3 cents per share.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The drug developer posted revenue of $423.9 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $416.3 million.
